Skip to main content
. 2022 Apr 5;15(4):450. doi: 10.3390/ph15040450

Figure 4.

Figure 4

(a) [O-methyl-11C]PD153035 whole-body distribution 30–40 min after injection in a healthy volunteer. Adapted from [44], with permission from SNMMI. (b) Baseline [O-methyl-11C]PD153035 PET in (A) an adenocarcinoma patient and (B) a squamous cell carcinoma patient, with corresponding CT before treatment (C,D) and 6 weeks after treatment (E,F). Adapted from [46], with permission from SNMMI.